³í¹®) Development and Validation of a Next-Generation Sequencing–Based Multigene Assay to Predict the Prognosis of Estrogen Receptor–Positive, HER2-Negative Breast Cancer ¼¿ï´ëº´¿ø ¿Ü°ú À¯¹æ¾Ï ¿¬±¸ÆÀ(ÇÑ¿ø½Ä, ÀÌÇѺ° ±³¼ö)